Home

Scott Leftwich

CIK 1991668 · last filed 2025-08-25

Scott Leftwich is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2024. The most recent filing shows the insider bought $250.0K of CLDI on Aug 25, 2025. Across all open-market trades the lifetime net is +$250.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $886 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$886

Companies

2

Total Filings

7

Lifetime Open-Market Net

$250.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLDI Director 8,248 $0.11 $886 $250.0K 3 2025-08-25
Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Director 493,686 $0.01 $2.9K $0 4 2024-10-15

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-08-25 CLDI Buy (P) +125,000 $250.0K EDGAR
2025-07-15 CLDI Grant (A) — $0 EDGAR
2025-01-03 CLDI Grant (A) +11,684 $0 EDGAR
2024-10-15 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) — $0 EDGAR
2024-07-02 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) +23,783 $0 EDGAR
2024-07-02 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) +67,187 $0 EDGAR
2024-01-04 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) +8,958 $16.1K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.